Ubs Group Ag Frequency Therapeutics, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.35 - $0.72 $846 - $1,740	-2,418 Reduced 56.34%	1,874 $0
Q2 2023 Aug 11, 2023	SELL	$0.33 - $0.48 $414 - $602	-1,255 Reduced 22.62%	4,292 $1,000
Q1 2023 May 12, 2023	SELL	$0.44 - $5.47 $924 - $11,487	-2,100 Reduced 27.46%	5,547 $2,000
Q4 2022 Feb 08, 2023	BUY	$1.88 - $3.85 $2,491 - $5,101	1,325 Added 20.96%	7,647 $29,000
Q3 2022 Nov 10, 2022	SELL	$1.46 - $2.55 $347 - $606	-238 Reduced 3.63%	6,322 $11,000
Q2 2022 Aug 10, 2022	SELL	$1.03 - $2.03 $8 - $16	-8 Reduced 0.12%	6,560 $10,000
Q1 2022 May 16, 2022	SELL	$1.7 - $5.72 $12,734 - $42,848	-7,491 Reduced 53.28%	6,568 $14,000
Q4 2021 Feb 14, 2022	BUY	$4.95 - $7.11 $65,072 - $93,468	13,146 Added 1439.87%	14,059 $72,000
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $6,319 - $8,399	-908 Reduced 49.86%	913 $7,000
Q2 2021 Aug 13, 2021	SELL	$8.05 - $11.61 $235,382 - $339,476	-29,240 Reduced 94.14%	1,821 $18,000
Q1 2021 May 12, 2021	BUY	$7.99 - $55.01 $234,075 - $1.61 Million	29,296 Added 1659.83%	31,061 $296,000
Q4 2020 Feb 11, 2021	BUY	$18.65 - $40.0 $18,351 - $39,360	984 Added 125.99%	1,765 $62,000
Q3 2020 Nov 12, 2020	SELL	$17.76 - $24.96 $158,774 - $223,142	-8,940 Reduced 91.97%	781 $15,000
Q2 2020 Jul 31, 2020	BUY	$14.65 - $24.9 $81,878 - $139,166	5,589 Added 135.26%	9,721 $226,000
Q1 2020 May 01, 2020	SELL	$16.36 - $27.55 $63,934 - $107,665	-3,908 Reduced 48.61%	4,132 $74,000
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $101,866 - $150,589	8,040 New	8,040 $141,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.